Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis.

Scientific Reports
Michael T C PoonPaul M Brennan

Abstract

Translation of survival benefits observed in glioblastoma clinical trials to populations and to longer-term survival remains uncertain. We aimed to assess if ≥ 2-year survival has changed in relation to the trial of radiotherapy plus concomitant and adjuvant temozolomide published in 2005. We searched MEDLINE and Embase for population-based studies with ≥ 50 patients published after 2002 reporting survival at ≥ 2 years following glioblastoma diagnosis. Primary endpoints were survival at 2-, 3- and 5-years stratified by recruitment period. We meta-analysed survival estimates using a random effects model stratified according to whether recruitment ended before 2005 (earlier) or started during or after 2005 (later). PROSPERO registration number CRD42019130035. Twenty-three populations from 63 potentially eligible studies contributed to the meta-analyses. Pooled 2-year overall survival estimates for the earlier and later study periods were 9% (95% confidence interval [CI] 6-12%; n/N = 1,488/17,507) and 18% (95% CI 14-22%; n/N = 5,670/32,390), respectively. Similarly, pooled 3-year survival estimates increased from 4% (95% CI 2-6%; n/N = 325/10,556) to 11% (95% CI 9-14%; n/N = 1900/16,397). One study with a within-population compari...Continue Reading

References

Oct 7, 2004·Cancer Research·Hiroko OhgakiPaul Kleihues
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 22, 2006·The Medical Journal of Australia·Mark A RosenthalGraham G Giles
Sep 6, 2007·Brain : a Journal of Neurology·Dietmar KrexUNKNOWN German Glioma Network
May 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Andrea SalmaggiFrancesca Imbesi
Dec 25, 2008·Annals of Neurology·Fabio M IwamotoLauren E Abrey
Apr 7, 2010·Neuro-oncology·Luc BauchetUNKNOWN Association des Neuro-Oncologues d'Expression Française (ANOCEF)
Oct 7, 2010·JAMA : the Journal of the American Medical Association·Frederick Kofi KorleyThomas Dean Kirsch
Apr 7, 2012·Current Problems in Cancer·Henry S ParkJames B Yu
Jun 5, 2012·Journal of Neuro-oncology·Kyu-Won JungSeung Hoon Lee
May 4, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Kathryn M FieldMark A Rosenthal
Aug 7, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian HartmannUNKNOWN German Glioma Network
Sep 21, 2013·Neuro-oncology·Robert DubrowJoseph T King
Oct 15, 2013·Cell·Cameron W BrennanUNKNOWN TCGA Research Network
Nov 2, 2013·Neurosurgery·Miriam NuñoChirag G Patil
Nov 7, 2013·JAMA : the Journal of the American Medical Association·Antonio Omuro, Lisa M DeAngelis
May 2, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R StuppUNKNOWN ESMO Guidelines Working Group
Aug 1, 2014·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma
Jan 15, 2015·International Journal of Radiation Oncology, Biology, Physics·Chad G RusthovenBrian D Kavanagh
Feb 11, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andrew BrodbeltUNKNOWN (UK) National Cancer Information Network Brain Tumour Group
Jun 11, 2015·PloS One·Li-Nien ChienJill S Barnholtz-Sloan
Feb 2, 2016·Environment International·Rebecca L MorganHolger J Schünemann
Apr 19, 2016·Cancer·Dorothee GramatzkiMichael Weller
Jun 28, 2016·Canadian Journal of Public Health = Revue Canadienne De Santé Publique·Yan YuanFaith G Davis
Oct 14, 2017·Current Medical Research and Opinion·Derek R JohnsonJoon H Uhm
Dec 15, 2017·Progress in Neurological Surgery·Quinn T OstromJill S Barnholtz-Sloan
Jun 9, 2018·Acta Neurologica Scandinavica·H BruhnJonas Lind
Jun 23, 2018·JAMA Oncology·Quinn T OstromJill S Barnholtz-Sloan
Aug 15, 2018·Scientific Data·Yuriy GusevSubha Madhavan
Nov 10, 2018·Neuro-oncology·Elisa AquilantiPriscilla K Brastianos

❮ Previous
Next ❯

Citations

Jan 29, 2021·Neuro-oncology Advances·Debra A GoldmanKatherine S Panageas
May 1, 2021·Cancers·Laura EscuderoJoan Seoane
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ana AlvesMarta Correia-da-Silva
Jun 11, 2021·Acta Pharmacologica Sinica·Delphine JiHong-Shuo Sun
Jun 18, 2021·Seminars in Cancer Biology·Peter W HalcrowJoyce E Ohm
Jul 3, 2021·Viruses·Nicole Mihelson, Dorian B McGavern
Jun 14, 2021·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Angela MweempwaJames R Whittle
May 18, 2021·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Anna Prieto-ColominaVíctor Borrell
Jul 25, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wei WuHeike E Daldrup-Link
Sep 21, 2021·Frontiers in Immunology·Saadia Ait SsiAbdallah Badou
Sep 29, 2021·Neuro-oncology·Massimiliano Del BeneGiuliana Pelicci

❮ Previous
Next ❯

Software Mentioned

GRADE
Plot Digitizer
ROBINS
Stata

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.